PEOPLE - Memry Corporation makes appointment:
This article was originally published in Clinica
Shape memory alloy technology firm Memry Corporation (Bethel, Connecticut) has appointed Eoin O'Madagain as European commercial director. He was most recently vice-president of Creganna Medical Devices in Galway, Ireland. His new role will involve responsibility for managing Memry's sales and activities throughout most of the European continent.
You may also be interested in...
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.